Charles Riv­er se­cures $50M ac­qui­si­tion of drug dis­cov­ery tech com­pa­ny

Over the past sev­er­al years, Mass­a­chu­setts-based con­trac­tor Charles Riv­er Lab­o­ra­to­ries has been busy on the M&A front, with the lat­est, $50 mil­lion buy­out com­ing Mon­day for a provider of high-through­put screen­ing so­lu­tions for dis­cov­ery re­search.

Chica­go-based SAM­DI Tech will now be fold­ed in­to Charles Riv­er’s dis­cov­ery and safe­ty as­sess­ment di­vi­sion, Charles Riv­er an­nounced.

The $50 mil­lion in cash is for the 80% of SAM­DI that Charles Riv­er didn’t pre­vi­ous­ly own. Oth­er fi­nan­cial de­tails on the deal were not dis­closed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER